Principal Owner, Senior Communications Consultant
CurrentABOUT JENNIFER CAMERONJennifer Cameron is an award-winning, public relations consultant with a bent on strategic communications planning, stakeholder engagement and investor relations. She is committed to developing measurable communications strategies designed to help clients bring their diverse teams together to advance their overall business strategy.As director of communications at Immunovaccine Inc., she is credited with developing the communications strategy to support the company’s initial public offering (IPO). Following the successful listing on the TSX venture exchange, Jennifer continued to manage all of Immunovaccine’s corporate branding, marketing and communications. She was responsible for mobilizing and capturing Immunovaccine’s new research developments and collaborations, ensuring technical information was effectively communicated to investors online, through social media, and in roadshow presentations. Through effective media relations Jennifer also raised the company’s profile, both locally and globally, with Immunovaccine being recognized as ‘best early stage biotech’ by the World Vaccine Congress.Jennifer has 10 years of agency experience, providing her with the know-how to operate her own consulting business where she develops communications, marketing, and branding tools for a host of clients. These tools include writing press releases, preparing award submissions, and managing the design, content and launch of corporate websites, complete with social media callouts.In addition to advising senior management on time-sensitive communications associated with media,government, investor and stakeholder relations, she offers media training to small business owners. She is a self-starter with great energy and her clients will tell you so. Her list of clients include Appili Therapeutics, BioNova, the Centre for Enhanced Genomic Medicine (CGEM), Dalhousie University, Densitas, Genome Atlantic, the Halifax Partnership and InnovMarine.
